phone icon (917) 310-3371 Explore Zepbound Menu
Nao Medical Logo

Zepbound vs Wegovy

This page is for patients deciding between the two leading branded obesity medications and trying to understand how efficacy, access, and follow-up differ in real life.

Zepbound and Wegovy are both once-weekly branded obesity medications, but Zepbound uses tirzepatide (GIP plus GLP-1) while Wegovy uses semaglutide (GLP-1 only). Lilly's SURMOUNT-5 results showed higher average weight loss with Zepbound than Wegovy at 72 weeks, but the better fit still depends on coverage, tolerability, refill stability, and whether the patient is already doing well on Wegovy.

Lilly publishes different savings and self-pay paths depending on insurance status. Commercially insured patients and self-pay patients can see very different pricing rules, while government beneficiaries often follow a separate access path. Program terms can change, so the workflow matters more than any one static number copied off the internet.

Keep the answer tied to the booking path The best support pages answer one specific question and then move the patient back into the live hub, location network, and broader GLP-1 family without dead ends.

What this page needs to clarify

Zepbound and Wegovy are both once-weekly branded obesity medications, but Zepbound uses tirzepatide (GIP plus GLP-1) while Wegovy uses semaglutide (GLP-1 only). Lilly's SURMOUNT-5 results showed higher average weight loss with Zepbound than Wegovy at 72 weeks, but the better fit still depends on coverage, tolerability, refill stability, and whether the patient is already doing well on Wegovy.

Mechanism

Zepbound contains tirzepatide and works through GIP plus GLP-1 pathways, while Wegovy contains semaglutide and works through GLP-1 alone.

Average weight-loss signal

Lilly's SURMOUNT-5 results reported average weight loss of 20.2% with Zepbound versus 13.7% with Wegovy at 72 weeks, but patients still need a real fit decision rather than a headline alone.

Coverage and refill stability

The more effective medication on paper is not always the easier medication to start, cover, or refill. Coverage rules and pharmacy stability can change the practical winner.

When Wegovy still makes sense

Patients who are already doing well on Wegovy, have better Wegovy coverage, or want the plan with less change may not need to switch just because Zepbound trends stronger on average.

How this fits into the broader GLP-1 plan

Nao Medical offers provider-guided Zepbound evaluation across NYC and Long Island, including coverage review, self-pay workflow planning, pharmacy-availability troubleshooting, and branded comparison against Wegovy when the patient is already searching by medication name.

Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Zepbound prescription coverage is separate from visit coverage and often depends on obesity-drug exclusions, prior authorization rules, employer carve-outs, and the pharmacy benefit.

Zepbound self-pay is usually a workflow, not just a price. It starts with the visit, medical review, and prescription, then moves into dose selection, pharmacy channel, program eligibility, refill timing, and follow-up. Some self-pay programs depend on staying inside refill windows, so operational planning matters.

Locations that can support the next visit

These existing weight-loss pages are the fastest way to move from research into a real Nao Medical location and booking path.

174th Street Zepbound support location

Bronx

174th Street

932 E 174th St, Bronx, NY 10460

A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.

View weight-loss location Get directions
Astoria Zepbound support location

Queens

Astoria

37-15 23rd Ave, Astoria, NY 11105

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.

View weight-loss location Get directions
Bartow Mall Zepbound support location

Bronx

Bartow Mall

2063A Bartow Ave, Bronx, NY 10475

A Bronx access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.

View weight-loss location Get directions
Crown Heights Zepbound support location

Brooklyn

Crown Heights

341 Eastern Pkwy, Brooklyn, NY 11216

A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.

View weight-loss location Get directions
Hicksville Zepbound support location

Long Island

Hicksville

232 W Old Country Rd, Hicksville, NY 11801

A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.

View weight-loss location Get directions
Jackson Heights Zepbound support location

Queens

Jackson Heights

80-10 Northern Blvd, Jackson Heights, NY 11372

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.

View weight-loss location Get directions
Jamaica Zepbound support location

Queens

Jamaica

90-18 Sutphin Blvd, Jamaica, NY 11435

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.

View weight-loss location Get directions
Long Island City Zepbound support location

Queens

Long Island City

30-07 36th Ave, Astoria, NY 11106

A Queens access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.

View weight-loss location Get directions
Mineola Zepbound support location

Long Island

Mineola

135 Mineola Blvd, Mineola, NY 11501

A Long Island access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.

View weight-loss location Get directions
StuyTown Zepbound support location

Manhattan

StuyTown

259 1st Ave, New York, NY 10003

A Manhattan access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.

View weight-loss location Get directions
Williamsburg Zepbound support location

Brooklyn

Williamsburg

308 Graham Ave, Brooklyn, NY 11211

A Brooklyn access point for provider-guided Zepbound visits, coverage planning, and follow-up support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.

View weight-loss location Get directions

Related Zepbound and GLP-1 pages

Questions patients still ask after the first click

Zepbound and Wegovy are both once-weekly branded obesity medications, but Zepbound uses tirzepatide (GIP plus GLP-1) while Wegovy uses semaglutide (GLP-1 only). Lilly's SURMOUNT-5 results showed higher average weight loss with Zepbound than Wegovy at 72 weeks, but the better fit still depends on coverage, tolerability, refill stability, and whether the patient is already doing well on Wegovy.
Possibly, but the choice depends on current dose, side effects, adherence, coverage, and whether the plateau is truly medication-related.
Yes. Coverage, availability, side-effect profile, and prior response can matter more than one average comparison when the goal is a stable long-term plan.
Patients leaning toward Zepbound should move into the insurance, self-pay, or availability pages. Patients staying with Wegovy should use the existing Wegovy hub and follow-up pages.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

The comparison page was much more practical than the usual Zepbound-vs-Wegovy article.

Verified Patient
(4.9)

Helpful that it covered coverage and refill stability instead of only the trial headline.

Verified Patient
(4.9)

This made the branded GLP-1 decision much less abstract.

Nao medical

Move from the guide to the next real step

Use the main Zepbound hub for the full lane, or pick a location page if you already know the visit needs to happen close to home.

Open main Zepbound hub